Recorded September 17, 2015

Sponsored by

Webinar Description:

Uncertainty around efficacy, safety, approval, and reimbursement makes drug development riskier than ever. Does your portfolio management process have what it takes to meet the ever-increasing demands of management, the board, and the street? In this webinar we’ll review processes, methods and tools that identify high-value portfolios in alignment with multiple, conflicting strategic goals, such as short- and long-term revenue.

Learning Objectives:

  • Learn about metrics for project valuation, their strengths and shortcomings
  • Explore useful methods for project prioritization, and understand their limitations
  • Review effective methods for assessing and managing project and portfolio risk
  • Understand the keys to preparing and facilitating a productive portfolio review


Richard SonnenblickRichard Sonnenblick, Ph.D.


Enrich Consulting


Richard Sonnenblick, the CEO of Enrich Consulting, has been with Enrich since its inception in 1998. The vision he brought to Enrich has been realized in the Enrich Analytics Platform. Prior to founding Enrich, he built a decision analysis consulting practice at Lumina Decision Systems, where he worked on integrated assessments of environmental legislation and R&D valuation models for high technology firms. Dr. Sonnenblick holds a Ph.D. and MS from Carnegie Mellon University in Engineering and Public Policy, and a BA in Physics from the University of California, Santa Cruz.